ABOUT BOB RHATIGAN:
Mr. Rhatigan is the CEO of Merz Americas, leading the company strategy and operations across the United States, Canada and Latin America.
Mr. Rhatigan holds a proven track record of successful business leadership, building strong teams and developing leading brands in the medical aesthetics arena. Prior to joining Merz in 2017, Mr. Rhatigan spent 17 years at Allergan where he completed his tenure as SVP, GM and Chief Executive of SkinMedica®.
Prior to this role, Mr. Rhatigan served as SVP of Allergan's Facial Aesthetic business, where he led the launches and marketplace success of BOTOX® Cosmetic, JUVÉDERM® and LATISSE® in the United States.
In addition to his experience in medical aesthetics, Mr. Rhatigan has extensive leadership and product launch experience across neurosciences, medical dermatology and eye care. Prior to Allergan, Mr. Rhatigan spent nine years at Procter & Gamble in a variety of roles of increasing responsibility in sales and marketing. Mr. Rhatigan most recently served as President and CEO of Merz North America.
Mr. Rhatigan was named the "Top Aesthetics CEO" by Aesthetic Everything in 2018 and 2017. Previous awards include: "Innovator in Dermatology" by the Cosmetic Surgery Forum in 2013, "Top 25 DTC Marketer" from DTC Perspectives in 2008, and "Excellence in Sales Leadership" from PDI in 2004.
Mr. Rhatigan is a member of Merz’s Global Executive Management Board, in addition to the boards for the Americas business.
Merz North America is a specialty healthcare company headquartered in Raleigh, North Carolina and dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives.
For more than 100 years, the development of our products has been based on Merz`s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany with a global focus on aesthetic medicine and neurotoxins.
In 2017, Merz was named the “Top Aesthetics Company” by Aesthetic Everything, and Bob Rhatigan, CEO of Merz North America, was named the “Top Aesthetics CEO.”